However, proper characterization of EVs requires identification of both a lipid membrane and EV surface markers such as tetraspanins CD9, CD63, or CD81, which while originally characterized for mammalian EVs, have now also been shown in EVs derived from mosquito cells cultured in vitro
(3) Lack of Early Indicators- prior to the cardiovascular outcomes trials (CVOTs), there was no strong evidence or clear biological indicators suggesting that this class of drug would have a direct effect on cardiovascular health
American Journal of Obstetrics and Gynecology, 220 (1), B2B18
Complete Intake Form 2
Participants in the Phase 3 TRIUMPH-4 trial taking 12mg at 68 weeks lost an average of 28.7% of their body weight the most significant result reported at that stage for any obesity-related compound to date
Risk factors include: People with diabetes, especially those with poor blood sugar control, are more prone to gastroparesis due to potential nerve damage affecting the stomach